FDA Inspection
Department of Defense - ArmyDepartment of Defense - Army – FDA Inspection, Feb 1, 2017
Record Details
This FDA Inspection record concerns Department of Defense - Army, with an inspection on February 1, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · cd3b8680-7d71-4d57-b361-0eac9d5382fe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1004242
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Department of Defense - Army
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 22, 2025 | NAI | Blood and Blood Products | |
| August 23, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 12, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 13, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 7, 2011 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Department of Defense - Army
- FDA Inspection 1259848 - 2025-01-22
- FDA Inspection 1101865 - 2019-08-23
- FDA Inspection 914406 - 2015-02-12
- FDA Inspection 847590 - 2013-08-13
- FDA Inspection 748945 - 2011-09-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.